-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Urethral adenocarcinoma (UrC-ADC) is an aggressive non-transitional epithelial tumor of the urethra, which is the remnant of the embryonic structure connecting the allantoic and fetal bladder.
Although 18 F-FDG PET/CT has shown value in many malignant tumors, UrC-ADC is often mucus-like in histology, and mucinous malignancies may show low or absent 18 F-FDG uptake.
18 18 18 18 18 Management of Jeeban P.
Caitlin Cancer Center 18 18 18
Standard illustration of patients screened and included in the analysis
Standard Graphical Screening of Patients Screened and Included in the AnalysisThere were 21 URC-ADC patients.
18 at 21 is patients, 18 18 F.
A 50-year-old male with UrC-ADC.
A 50-year-old male with UrC-ADC.
A 47-year-old male UrC-ADC.
A 47-year-old male UrC-ADC.
18 Compared with the cross-sectional imaging performed within 6 weeks before surgery, 18 F-FDG PET/CT found additional metastases in nearly 40% of patients, and according to radiological criteria, it was found in nearly 15% of patients End-stage disease.
18 F-FDG PET/CT has clinical practical value in UrC-ADC patients.
snmjournals.
snmjournals.
Leave a message here